Digital Biomarkers Becoming Integral to Precision Medicine


In a new commentary for Pharmaceutical Market Europe, Precision for Value’s Austin Speier, VP, Emerging Technology, examines the promise and advantages of integrating digital biomarkers into precision medicine. He highlights the ways life sciences companies are using the innovative technology to measure physiological, cognitive, or behavioral characteristics.

To read the complete commentary, please click here (pgs. 22-23)


Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.